The WHS Regional Meeting brings together leading researchers, physicians, government officials and representatives from industry, non-governmental organizations (NGOs) and healthcare systems worldwide.
Among the confirmed speakers for this year's Summit are:
(in alphabetical order)
Government Keynote Speakers
Dr Gaétan Barrette is Quebec’s Minister of Health and Social Services since 2014. A 1985 graduate in medicine of l’Université de Montréal, Dr Gaétan Barrette became a member of Royal College of Physicians and Surgeons of Canada in 1989. In 1991, he pursued a Fellowship in Vascular and Surgical Radiology at the University of California, San Diego. He currently practises at Maisonneuve-Rosemont hospital where he has been an active member since 1990. Dr. Barrette has been President of the Fédération des médecins spécialistes du Québec between 2006 and 2014. He was also Chairman of the Board of the Financière des professionnels inc. which manages a $2 billion portfolio. He was also a member of the Boards of the Régie de l’assurance maladie du Québec (RAMQ). Dr Barrette participates regularly in various conferences and forums on the subject of specialized medicine throughout Quebec, across Canada and abroad.
Geoffrey Kelley holds a bachelor’s degree in history and a master’s degree in modern Canadian history from McGill University. He taught for 15 years before joining Alliance Québec for several years, then became a political attaché and chief of staff. He oversaw questions such as education, higher education, the Charter of the French language, municipal affairs and public security.
He was initially elected MNA for Jacques-Cartier in 1994. He subsequently chaired a number of committees, including the Committee on Public Administration, the Committee on Social Affairs, the Committee on Education, the Committee on Health and Social Services, and the Select Committee on Dying with Dignity. He served several times as official opposition critic for Aboriginal affairs, the Far North and the family and was also responsible for relations with the English-speaking community. He has achieved recognition above all for his role as Minister for Native Affairs and Minister responsible for Native Affairs, a position that he has occupied several times. He is serving his seventh consecutive mandate as MNA for Jacques-Cartier. In April 2014, he was appointed Minister responsible for Native Affairs for the third time.
Prior to entering politics, Dr. Philpott led an extensive career in family medicine, public health, medical education and global advocacy for HIV/AIDS. Dr. Philpott studied medicine at the University of Western Ontario, completed a Family Medicine residency at the University of Ottawa, and a Tropical Medicine fellowship in Toronto. In 2012, she completed a Master of Public Health degree at the University of Toronto. Between 1989 and 1998, Dr. Philpott lived in Niger Republic, West Africa where she practiced general medicine and helped to develop a training program for village health workers. She practiced as a family physician at Markham Stouffville Hospital for more than 15 years and served as Chief of Family Medicine from 2008 to 2014. She also led the opening of the Health for All Family Health Team – a new primary care home for 10,000 patients in Markham-Stouffville, and the Markham Family Medicine Teaching Unit that has trained 45 new family physicians in the community since 2010. Additionally, she is an Associate Professor in the University of Toronto’s Department of Family & Community Medicine. Some of her global advocacy work includes founding Give a Day to World AIDS in 2004, which has raised over $4 million to help those affected by HIV/AIDS in Africa. Dr. Philpott was the first Family Medicine lead for the Toronto Addis Ababa Academic Collaboration, where she was instrumental in helping Addis Ababa University develop Ethiopia’s first training program for Family Medicine.
Timothy Caulfield is a Canada Research Chair in Health Law and Policy, a Professor in the Faculty of Law and the School of Public Health at the University of Alberta and Research Director of the Health Law Institute at the University of Alberta. Over the past several years he has been involved in a variety of interdisciplinary research endeavours that have allowed him to publish over 300 academic articles. He is a Fellow of the Trudeau Foundation and the Principal Investigator for a number of large interdisciplinary projects that explore the ethical, legal and health policy issues associated with a range of topics, including stem cell research, genetics, patient safety, the prevention of chronic disease, obesity policy, the commercialization of research, complementary and alternative medicine and access to health care. Professor Caulfield is and has been involved with a number of national and international policy and research ethics committees. He has won numerous academic awards and is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences. He writes frequently for the popular press and is the author of two recent national bestsellers: The Cure for Everything: Untangling the Twisted Messages about Health, Fitness and Happiness (Penguin 2012) and Is Gwyneth Paltrow Wrong About Everything?: When Celebrity Culture and Science Clash (Penguin 2015).
Dr Noel Hayman was one of the first two Indigenous medical students to graduate from the University of Queensland in 1990. Noel is Clinical Director of the Inala Indigenous Health Service in Brisbane. In developing this service, he has been instrumental in demonstrating how mainstream primary health care services can be made appropriate to the needs of urban Aboriginal populations. Noel’s interests include improving Indigenous access to mainstream health services and supporting medical education in Indigenous health. Professor Hayman received the 2003 Centenary Medal for his long service to primary health care in Aboriginal communities and the 2007 inaugural Close the Gap Indigenous Health Award (Australians for Native Title and Reconciliation Queensland). In 2011 he was Queensland Australian of the Year. Noel is on numerous National and State Committees.
Brian D. Hodges MD, PhD, FRCPC is Professor in the Faculty of Medicine and Faculty of Education (OISE/UT) at the University of Toronto; the Richard and Elizabeth Currie Chair in Health Professions Education Research at the Wilson Centre for Research in Education and Executive Vice President Education at the University Health Network (Toronto General, Toronto Western Princess Margaret and Toronto Rehab Hospitals). He leads the AMS Phoenix Project: A Call to Caring, an initiative to rebalance the technical and compassionate dimensions of healthcare.
Dr Joanne Liu commenced her term as International President of Médecins Sans Frontières (MSF) on 1 October 2013. Her time with MSF started in 1996, when she worked with Malian refugees in Mauritania. Since then, she has provided support after the tsunami in Indonesia, assisted people affected by the earthquake and cholera epidemic in Haiti, and worked with Somali refugees in Kenya and displaced populations in North Kivu, Democratic Republic of Congo (DRC). She has worked in many conflict zones, including in Palestine, Central African Republic, DRC and Sudan’s Darfur region. Born in Quebec City, Canada, Dr Liu trained at McGill University School of Medicine, and specialised in paediatrics at Montreal’s Sainte-Justine hospital. She holds a fellowship in paediatric emergency medicine from New York University School of Medicine, and an International Master’s in Health Leadership from McGill University. She is also an associate professor at the Université de Montréal and a professor in practice at McGill University.
Janet Rossant, CC, PhD, FRS, FRSC is Senior Scientist and Chief of Research Emeritus at the Hospital for Sick Children in Toronto and President and Scientific Director of the Gairdner Foundation. She is an internationally recognized developmental and stem cell biologist, exploring the origins of stem cells in the early embryo and their applications to understanding and treating human disease. She led the research institute at the Hospital for Sick Children from 2005 to 2015. She has received many honours and recognition for her work, including four honorary degrees, and election to the Royal Societies of London and Canada, and the National Academy of Sciences, USA.
George Alberti has had a longstanding interest in diabetes and metabolism. He has worked extensively in Tanzania and Mauritius. He has particular interests in the metabolic syndrome and also diagnostic tests for diabetes & has participated in several WHO Expert Committees and working groups relating to diabetes. He has published more than 1100 papers and chapters.
Dr. Marie Archambault received her Doctor of Veterinary Medicine degree from the University of Montreal in 1993. She obtained an MSc in Veterinary Pathology and Microbiology in 1995, a PhD in Microbiology and Immunology in 2000. From 1999 to 2004, she was the head bacteriologist at the Animal Health Laboratory of the University of Guelph where she was also an Adjunct Faculty member. She joined the University of Montreal as a Faculty member in 2004. Her areas of research include antibiotic resistance in veterinary and zoonotic pathogens. Her Natural Sciences and Engineering Research Council of Canada (NSERC) research program is on the investigations into the association between antibiotic resistance and virulence factors of Gram-positive organisms with a focus on Clostridium perfringens. She has also developed a strong research program on Livestock-Associated-Methicillin-Resistant Staphylococcus aureus with the government of Quebec. She is the author/co-author of more than 40 publications in peer-reviewed scientific journals on the topic of antibiotic resistance. She also co-edited the second edition of the Clinical Veterinary Microbiology textbook.
Clare Bambra PhD is Professor of Public Health Newcastle University Medical School (UK). Her research focuses on the health effects of labour markets, health and welfare systems, as well as the role of public policies to reduce health inequalities. She has published extensively including How Politics Makes Us Sick: Neoliberal Epidemics (Palgrave Macmillan, 2015) and Health Divides: Where you live can kill you (Policy Press, 2016). She can be followed on Twitter @ProfBambra
Christian Baron received a Ph.D. in Microbiology at the Ludwig-Maximilians University in Munich in August Böck’s group in the Department of Microbiology in 1993, followed by postdoctoral research with Patricia C. Zambryski at UC Berkeley (CA, USA). In 1997 he returned to Munich as University Assistant to build his independent research group in the Department of Microbiology and in 2002 he was recruited as Associate Professor in the Biology Department at McMaster University in Hamilton (ON, Canada). In 2008 he joined the Department of Biochemistry at the Université de Montréal (QC, Canada) as Full Professor and Chair. In 2015 he was nominated as Vice-Dean of Research and Development at the Faculty of Medicine.
Associate professor, School of Industrial Relations, Université de Montréal
Nancy Beauregard, holds a PhD in population health from University of Ottawa. She is an associate professor at the School of Industrial Relations, University of Montreal. She is also a regular researcher at the Institut de recherche en santé publique de l’Université de Montréal (IRSPUM). Nancy Beauregard is interested in the influence of organizational context, and in particular, of the organizational learning process, on occupational health and safety. In addition, her recent work focuses on the association between work injuries and mental health among the workforce. Her researches on at risk industrial sectors and occupations have received financial support from the Institut de recherche Robert-Sauvé en santé et en sécurité du travail (IRSST). Hence, the theme of agricultural health and safety crosses her main research interests.
Dr. Marcel Behr is Professor of Medicine at McGill University where he is Director of the McGill International TB Centre and Microbiologist-in-Chief of the McGill University Health Centre. His training included BSc (Biochemistry) from the University of Toronto, MD from Queen’s University, Residency training in Infectious Diseases and Medical Microbiology at McGill, an MSc (Epidemiology) from McGill and then post-doctoral studies of Molecular Epidemiology and Bacterial Genomics at Stanford. Dr. Behr’s research interest is the application of bacterial genetics to study the epidemiology and pathogenesis of mycobacterial diseases, specifically, M. tuberculosis, BCG, and non-tuberculous mycobacteria, including members of the M. avium-intracellular complex. This work has been recognized by numerous awards, in Quebec (Chercheur National of the Fonds de la Recherche en Sante du Quebec) and beyond (Fellow of the Canadian Academy of Health Sciences, 2016 and Election to the American Society for Clinical Investigation, 2010).
Professor Robin Bell MBBS (Hons) PhD MPH FAFPHM Grad Cert Health Professional Education. Professor Robin Bell is the Deputy Director of the Women’s Health Research Program in the School of Public Health and Preventive Medicine at Monash University in Melbourne, Victoria, Australia. Professor Bell is a medical epidemiologist specializing in the health of women at midlife and older and has published 180 peer reviewed publications. Professor Bell is also the Curriculum and Assessment Lead for one of the 4 vertical themes in the medical course at Monash, the theme of Society, Population, Health and Illness. Professor Bell teaches population health, health promotion and prevention science as well as a module on the health of women at midlife. Monash University currently has an undergraduate medical course, a post-graduate course and a separate campus with a medical course in Malaysia. There are, in total, about 500 students in each year level of the medical courses at Monash.
Victoria is Chair of the Australian Medical Students’ Association, a graduate of Monash University, and is a junior doctor at the Alfred Hospital in Melbourne. She has been heavily involved in medical leadership and particularly in the wellbeing and rights of medical students. She has advocated locally, nationally and internationally for the mental health of medical students as President of the Monash University Medical Society where she worked on bullying advocacy as well as whistleblowing and reporting procedures. On an international level, Victoria worked as the inaugural Mental Health Program Coordinator for the International Federation of Medical Students’ Associations, discussing experiences with and creating tools for students from around the world.
She is passionate about non-formal education in the medical curriculum and believes that to learn broadly and with enthusiasm in fields beyond medicine will make students more holistic, empowered, people-focussed doctors, with greater influence to enact change within our societies.
Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders. His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders. Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute.
Dr. Blouin serves as Secretary for the Committee on Accreditation of Canadian Medical Schools (CACMS) and for the Committee on Accreditation of Continuing Medical Education (CACME). She still maintains an active academic clinical practice in Emergency Medicine at Queen’s University, and was granted professorship in 2012. In 2003, she completed a Master of Health Professions Education degree at the University of Illinois at Chicago, followed in 2016 by a doctorate degree in Curriculum and Instruction from the same university. She has been involved as an educator and scholar in numerous projects at the provincial, national and international levels. Her research interests centre on curriculum development and program evaluation.
Appointed Dean of the Faculty of Medicine at Université de Montréal in June 2011, Dr. Boisjoly is recognized as an accomplished corneal surgeon and ophthalmologist who have influenced a generation of students in Ophthalmology, Cornea and Eye research. She obtained her MD and a post graduate training in Ophthalmology from the Université de Sherbrooke. She was a Cornea fellow at the Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute (Harvard University) and holds a Master in Public Health degree from the Bloomberg School of Public Health (Johns Hopkins University). In Canada, she was a FRSQ Research Scientist (1986-2000) and Scientific Director of the FRSQ Vision Research Network (1996-2000). She held a number of key positions in Ophthalmology both at Université Laval (1983-1993) and Université de Montréal (since 1993) including Head of the Department of Ophthalmology at Maisonneuve-Rosemont Hospital (1993-1998) and Chair of the Department of Ophthalmology (2000-2008).
Kym Boycott is a Medical Geneticist at the Children’s Hospital of Eastern Ontario (CHEO), Senior Scientist at the CHEO Research Institute, and Professor of Pediatrics at the University of Ottawa. Dr. Boycott’s research program in rare diseases bridges clinical medicine to basic research and is focused on understanding the molecular pathogenesis of these disorders, enabling the design of new therapies to ultimately benefit patients and their families. She is the principal investigator of Canada’s national genome-wide sequencing platform for rare disease, Care4Rare Canada, and of the Rare Diseases: Models & Mechanisms Network, established to catalyze connections between clinical investigators discovering new genes in patients with rare diseases and basic scientists who can analyze equivalent genes and pathways in model organisms. Dr. Boycott moves the international rare disease agenda forward through her role as the Chair of the Diagnostics Committee of the International Rare Diseases Research Consortium.
Professor Alex Brown is an Aboriginal medical doctor and researcher from the south coast of New South Wales, Australia. He studied Medicine at the University of Newcastle (NSW), an MPH at Hebrew University in Israel, and his PhD from University of Queensland in cardiovascular epidemiology. He is currently Chair in Aboriginal Health at the University of South Australia and Deputy Director and Theme Leader Aboriginal Health at the South Australian Health and Medical Research Institute. Alex has established an extensive and unique research program focused on chronic disease in vulnerable communities, with a particular focus on outlining and overcoming health disparities. He leads projects encompassing cardiometabolic epidemiology, understanding the psychosocial determinants of chronic disease, mixed methods health services research, and trials of pharmacological and non-pharmacological chronic disease interventions. In July 2012, Alex joined SAHMRI to develop and lead a state-wide Aboriginal health research program. He leads a team of 52 staff, 29 of whom are Indigenous. He was recently admitted to the Australian Academy of Health and Medical Sciences.
Dr Julie Bruneau is Professor in the Department of Family and Emergency Medicine at Université de Montréal. She is currently Head of the Primary Care Department at the Centre Hospitalier de l’Université de Montréal (CHUM). She is recognized as a leader in addiction medicine in Canada. At the CHUM, she implemented what became the largest academic mental health and addiction medicine facility in the province, where she is still practicing. Over the past 20 years, her research contributed to a better understanding of factors impeding and facilitating harm reduction efforts (such as syringe exchange and Opioid Agonist Therapy (OAT) to reduce HCV and HIV transmission and comorbidities among persons who inject drugs. She is currently the leader of the Quebec-Maritimes node of the Canadian Research Initiative on Drug Misuse, and a core-leader in the Canadian HEPC Research Network.
Dr. Brunet is the Chief Executive Officer of the Centre hospitalier de l’Université de Montréal (CHUM) and of the Centre hospitalier universitaire Sainte-Justine (CHU Sainte-Justine), a role he has occupied since September 7, 2015. From 2009 to 2015, he was the Director General of the CHU Sainte-Justine, before becoming its CEO. He is Vice-President of the Integrated University Health Network of the Université de Montréal (RUIS) and a full clinical professor at the Department of Pediatrics of the Université de Montréal. He is also a professor of resuscitation medicine in France and a professor of medicine at the University of Toronto. Dr. Fabrice Brunet studied medicine at the Faculty of Cochin Port-Royal, University of Paris V. He later specialized in cardiology, medical resuscitation and emergency medicine. He has also occupied several roles in the medical field across Europe and America, with a particular focus on research and teaching. Early in his career, he attended the École Supérieure de Commerce de Paris (ESCP), where he completed his medical education by studying management in a healthcare context, and eventually became a professor of hospital management. Dr. Brunet completed his management studies at Harvard University and at the University of Toronto and became a professor of healthcare at the HEC Montréal. Before he started working at the CHU Sainte-Justine, he was Director of the Department of Resuscitation and Intensive Care at the St. Michael's Hospital in Toronto and Medical Director of its telemedicine program.The experience that Dr. Brunet has garnered over the course of his career will be used to continuously improve the care that is provided to the residents of the CHUM and CHU Sainte-Justine and to respond to their needs, from birth until death.
Agnès Buzyn is Professor of Hematology at the University Pierre-and-Marie-Curie in Paris. She spent a large part of her career as an academic hematologist and clinician at the University Paris Descartes - Necker Hospital, where from 1992 to 2011 she headed the adult hematology intensive care and bone marrow transplants unit. From 2002 to 2006, Professor Buzyn was the Director of a research team on tumor immunology at the National Institute of Health and Medical Research (INSERM). Her research activities have focused on bone marrow transplants, and leukemias (ALL,CML).
A. Buzyn has served as board member of a number of national organizations: the Biomedicine Agency (ABM), the Blood Institute (EFS), the bone marrow transplant and cell therapy society (SFGM-TC). From 2008 to 2013, she served as Chair of the Board of the Radioprotection and Nuclear Safety Institute (IRSN). A. Buzyn was President of the French National Cancer Institute (INCa) from May 2011 until February 2016. She has been appointed Chairwoman of the French National Authority for Health (HAS – Haute Autorité de santé) on 7 March 2016.
Carolyn Canfield works across Canada and internationally as a citizen-patient to transform healthcare culture for better patient outcomes and worker satisfaction. Her passion is for expanding opportunities for patients and families to partner with healthcare professionals in every aspect of care: practice improvement, service design, policy, evaluation, training and research. Frequent roles include keynote speaker, course instructor, seminar leader, patient engagement coach and strategic advisor. At the University of British Columbia, Carolyn is teaching undergraduate medical and nursing students, clinician-researchers and graduate students. Her energetic full-time commitment to better healthcare arises from premature widowhood in 2008 following preventable harm, unacknowledged as a system failure and ignored for organizational learning. Carolyn holds the position of honorary lecturer in the Faculty of Medicine at the University of British Columbia. In 2014 she was honoured as Canada’s first individual Patient Safety Champion by Accreditation Canada and the Canadian Patient Safety Institute.
Ben Canny is Head of the School of Medicine at the University of Tasmania, where he has responsibility for Medicine, Pharmacy and Paramedicine. Prior to this he was the convenor of the Medical Degree at Monash University. Ben has always had a vital interest in Medical Education and Medical Science, and has led the Medical Education initiative of the M8 Alliance. At present, he is leading the development of a harmonized curriculum of Global Health Education for Health Professionals to be shared by members of the M8 Alliance. He is also Vice-President of the Australian and New Zealand Associate for Health Professional Educators.
Basile Chaix, as a social epidemiologist, seeks to understand how the multiple environments visited during daily life activities and related transport mode use influence health status. He was promoted as a Research Director in 2013 at Inserm. He is the coordinator of the Nemesis research team. He is the principal investigator of the RECORD Cohort Study. The RECORD GPS and MultiSensor studies have developed a tracking methodology combining GPS receivers (and other sensors) with an electronic mobility survey. For the next years, the team will focus on the MobiliSense project (European Research Council), a cohort of 1000 participants intensively monitored with sensors and smartphones, to explore the short-term and longer-term effects of air pollution and noise related to personal transport behavior on cardiovascular and respiratory health. Basile Chaix is part of the editorial board of Epidemiology, Social Science and Medicine, and Health & Place.
Dr. Omar Cherkaoui is a junior doctor freshly graduated from the University of Rabat, Morocco. He is the President of the International Federation of Medical Students' Associations (IFMSA), one of the world’s oldest and largest student-run organizations, that represents, connects and engages every day with medical students from 122 countries. Dr. Omar Cherkaoui is a strong advocate of health for all, and draws his passion from the work the Federation is doing globally to educate and build capacity of future health professionals on various global health topics. Prior to being President, he was Director of the IFMSA Professional Exchange Program, that gives the opportunity every year to over 14.000 medical students from around the world to go abroad, allowing them to experience different health systems. He also served the IFMSA as New Technologies Director, and advocated for the importance of technology and telemedicine for medical students.
Connie Clement is the Scientific Director of the National Collaborating Centre for Determinants of Health, located at St Francis Xavier University in Antigonish, NS. Prior to joining the NCCDH Connie has held positions as Director of Planning and Policy at Toronto Public Health, along with other management and front line positions. She is past Executive Director of Health Nexus/Nexus Santé, a key Ontario-based health promotion resource organization, and of Social Venture Partners Toronto, a venture philanthropy collaborative. In 2014, Connie was awarded the Canadian Public Health Association’s certificate of merit. She has a long history as a volunteer, is a proud mother and loves living on salt water.
Doctor Éric A. Cohen is Director of the Laboratory of Human Retrovirology at the Institut de recherches cliniques de Montréal (IRCM). He is also Professor of Virology at the Department of Microbiology, Infectiology and Immunology at the Université de Montréal and recipient of the IRCM-Université de Montréal Chair of Excellence in HIV Research. Dr. Cohen’s research aim to better understand HIV-host interactions regulating viral replication, transmission, and persistence. His studies on the interactions between HIV and antiviral effectors of the host innate immune response have fostered a transforming understanding of HIV persistence and opened new avenues for the development of HIV curative strategies. Dr. Cohen is a fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences and a member of the editorial board of Retrovirology. Since 2014, he leads the Canadian HIV Cure Enterprise (www.cancurehiv.org), a pan-Canadian multidisciplinary research consortium dedicated to HIV cure research.
Ashlee Cunsolo is a passionate researcher and environmental advocate, working with research and policy to make a difference in how we live with and in this world. As a community-engaged social science and health researcher working at the intersection of place, culture, health, and environment, she has a particular interest in the social, environmental, and cultural determinants of Indigenous health, intercultural learning and dialogue, environmental ethics, and the social justice implications of social, environmental, and health inequality. For the past 10 years, she has been working in partnership with Inuit across Canada examining the ways in which climate change is impacting health and wellness. She is a former Tier II Canada Research Chair and Associate Professor, is a member of the Royal Society of Canada’s College of New Scholars, Artists, and Scientists, and is one of Nature Canada’s 75 Women for Nature. She is currently the Director of the Labrador Institute in Happy Valley-Goose Bay.
Peter E. Dieter, Ph. D., est professeur de biochimie médicale à la Faculté de médecine Carl Gustav Carus de la Technische Universaität à Dresde, en Allemagne. Il a été un des premiers en Allemagne à réformer les vieux programmes de médecine (dont celui de Dresde) au profit d’un programme interdisciplinaire moderne, intégratif et basé sur l’apprentissage par problème. Peter Dieter est membre de nombreuses organisations allemandes et internationales impliquées dans l’éducation médicale, les programmes d’assurance de la qualité et l’accréditation. Il a eu un rôle à jouer dans l’accréditation et l’évaluation des programmes de médecine de nombreuses écoles de médecine en Allemagne, en Europe et en Asie, un rôle qu’il défend encore aujourd’hui. Il est également président de la Association of Medical Schools in WHO Europe (AMSE), à Berlin. En tant que tel, il tente de mettre en place une procédure d’assurance de la qualité (accréditation) uniforme en Europe qui serait reconnue par tous les pays, parce que basée sur les normes des programmes de premier cycle de la Fédération mondiale pour l’éducation médicale.
Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Australia, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of natural history of acute and chronic HCV infection, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs. He holds large-scale ongoing public sector research funding from U.S. National Institutes for Health, and Australian National Health and Medical Research Council (NHMRC). Professor Dore has been President of the Australasian Society for HIV Medicine (ASHM), a member of NHMRC Council, and currently is a NHMRC Practitioner Fellow.